Article
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
27 Jan 2014
Abstract excerpt
BACKGROUND: Tumor spreading is the major threat for cancer patients. The recently published anti-cancer drug salinomycin raised hope for an improved treatment by targeting therapy-refractory cancer stem cells. However, an unambiguous role of salinomycin against cancer cell migration and metastasis formation remains elusive. FINDINGS: We report that salinomycin effectively inhibits cancer cell migration in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
